Ngo-2028, imarike yokugcwaliswa kwedermal iya kufikelela kwi-6.28 yeebhiliyoni zeedola zaseMelika

Pune, India, Novemba 30, 2021 (GLOBE NEWSWIRE) - Imarike yehlabathi yokuzalisa i-dermal kulindeleke ukuba ifikelele kwi-6.28 yeebhiliyoni zeedola zaseMelika ngo-2028, kwaye kwangaxeshanye, izinga lokukhula konyaka elihlanganisiweyo ukusuka kwi-2021 ukuya kwi-2028 liya kufikelela kwi-10.8%.Abantu bachukumisekile. Kwisihloko sayo esithi “dermal filler market 2021-2028″, “Fortune Business Insights” ikhankanye ukuba ubungakanani bemarike ngo-2020 buya kuba yi-2.84 yeebhiliyoni zeedola zaseMelika.
Utyalo-mali olwandayo kwisebe le-R&D kwishishini lezithambiso zonyango kulindeleke ukuba liqhube ukukhula kwemarike yokuzalisa i-dermal. Ukongeza, indlela enyukayo kunye nokuxhaphaka konyango lokuzalisa kuye kwanda kakhulu kule minyaka idlulileyo. Umzekelo, kwingxelo ka-2019 ngu i-International Society of Aesthetic Plastic Surgery (ISAPS), kuqikelelwa ukuba utyando oluqikelelwa kwi-4,315,859 olubandakanya izizalisi ze-hyaluronic acid lwenziwa kwihlabathi liphela ngo-2019. Eli nani linyuke nge-15.7% ngo-2018.
Cela ikopi yesampulu yengxelo yophando: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
Impembelelo ye-COVID-19 icacile kwicandelo lokhathalelo lwempilo kuba isembindini walo mceli mngeni wobhubhane wehlabathi jikelele. Ishishini lezithambiso zonyango lichaphazeleka ngakumbi kuba ayibalulekanga kwaye iyinkonzo yokuzikhethela. ishishini liye labona ukuphazamiseka kwekhonkco lokubonelela ngenxa yokuthintela ukungenisa kunye nokuthumela ngaphandle, ukuvalwa kwendiza, ukunciphisa imveliso, kunye nokuphazamiseka kwemijelo yokubonelela.Ngokomzekelo, ingeniso yeJUVEDERM Collection ye-ALLERGAN (AbbVie, Inc.), umdlali onamandla kwimarike yehlabathi, yehle nge-42.3% xa kuthelekiswa nonyaka-mali ka-2019 (FY) .Nangona kunjalo, imarike kulindeleke ukuba iphumelele kwakhona ngexesha loqikelelo.
Ngokwezixhobo, imarike yahlulwe yaba yi-hyaluronic acid, i-calcium hydroxyapatite, i-poly-l-lactic acid, i-PMMA (i-poly (i-methyl methacrylate)), izihluzi ezinamafutha, njl. I-biodegradable.Ngokwesicelo sayo, imarike ihlukaniswe ngonyango lwe-scar, unyango lokulungiswa kwemibimbi, ukunyuswa komlomo, kunye nokubuyiselwa ngokupheleleyo.Kubasebenzisi bokugqibela, ihlukaniswe kwiikliniki zeengcali kunye ne-dermatological, izibhedlele kunye neekliniki, njl.
Ngokomkhwa, isabelo semarike yecandelo le-hyaluronic acid sesona siphezulu ngo-2020, kwi-77.1%.Oku kungenxa yokunyuka kwemfuno yeemveliso ze-hyaluronic acid ngenxa yokhuseleko lwazo kunye nobomi obude.Ngaphezu koko, iinkampani ezininzi zibonelela nge-hyaluronic acid. Iimveliso kumazwe anoqoqosho oluzinzileyo nolukhula kakhulu olunje ngeYurophu.Kulo mmandla, i-AbbVie, Inc. kulindeleke ukuba ikhuthaze ukukhula kweli candelo ngexesha loqikelelo.
Ingxelo yoPhando lweMarike yokuThenga-iDermal Filler: https://www.fortunebusinessinsights.com/checkout-page/100939
Ngenxa yengeniso ephezulu yokulahlwa kwabantu kulo mmandla, uMntla Merika kulindeleke ukuba ugcine isikhundla sawo esiphambili kwaye ube kwindawo ephezulu kwintengiso ngexesha loqikelelo. Ukongeza, kulindeleke ukuba imithetho engqongqo kunye nemimiselo enxulumene neemveliso ezintsha ziya kuthi. Umzekelo, ngokwedatha evela kuMbutho waseMelika wooGqirha bePlastiki (ASPS), ngo-2019, malunga ne-16.3 yezigidi zeenkqubo zokuthambisa zenziwe kancinci eUnited States, kwaye ubungakanani bentengiso ngo-2020 yayise-US. I-1,22 yeebhiliyoni zeedola.
Ummandla we-Asia-Pacific kulindeleke ukuba ubonise isabelo esikhulu semarike seenkonzo zokubamba. Oku kungenxa yokwanda kolwazi lwabantu malunga nenkangeleko yabo kwindawo. Ulingo lwezonyango lwe-dermal filler ekumgangatho ophezulu ebizwa ngokuba yi-YVOIRE Y-Solution e-China.Ke ngoko, ukusungulwa kwayo kulindeleke ukuba konyuse imakethi yengingqi ngexesha loqikelelo.
Ngaba uyathandabuza? Dibana neengcali zethu: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939
Iinkampani ezinkulu zizama ukugcina isikhundla sazo ngokugxila ekukhutshweni kweemveliso ezintsha, ngaloo ndlela zidibanisa imarike.Ngokomzekelo, ngo-Agasti ka-2020, i-Revance Therapeutics, Inc. yasungula i-RHA Dermal Filler Line.Yeyokuqala kunye ne-dermal filler evunyiweyo kuphela. i-FDA ukulungisa imibimbi yobuso obuguquguqukayo kunye nemibimbi e-United States.Eli qhinga elinobundlobongela kulindeleke ukuba liqhube imarike kwiminyaka embalwa ezayo.
Fumana ingxelo yakho yophando eyenziwe ngokwezifiso: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939
I-Fortune Business Insights™ ibonelela ngohlalutyo lweshishini lobuchwephesha kunye nedatha echanekileyo ukunceda imibutho yabo bonke ubukhulu ukuba benze izigqibo ngexesha.Silungiselela izisombululo ezitsha zabathengi bethu ukubanceda bamelane nemiceli mngeni ekhethekileyo abajongene nayo ishishini labo.Injongo yethu kukubonelela abathengi bethu ngemarike ebanzi. ubukrelekrele kunye nesishwankathelo esineenkcukacha zeemarike abasebenza kuzo.
Ingxelo yethu iqulethe indibaniselwano ekhethekileyo yokuqonda okubonakalayo kunye nohlalutyo lomgangatho wokunceda iinkampani zifikelele ekukhuleni okuzinzileyo.Iqela lethu labahlalutyi abanamava kunye nabacebisi basebenzisa izixhobo zophando eziphambili kushishino kunye nobuchule bokuqulunqa uphando olubanzi lwemarike, luxutywe neenkcukacha ezifanelekileyo.
Kwi-Fortune Business Insights™, injongo yethu kukuqaqambisa awona mathuba okukhula anengeniso kubathengi bethu.Ngoko ke, sinikezela ngeengcebiso ukuze bakwazi ukuphendula ngokulula kutshintsho lwetekhnoloji kunye nemarike.Iinkonzo zethu zokubonisana zenzelwe ukunceda imibutho ibone efihliweyo. amathuba kunye nokuqonda imingeni ekhoyo yokhuphiswano.
Fortune Business Insight™ Pvt.Ltd.I-308, ubuNkokheli obuPhakamileyo, i-Survey No. 36, i-Baner, i-Pune-Bangalore Highway, i-Pune-411045, i-Maharashtra, i-Indiya.
Phone: United States: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.comFortune Business Insights™ LinkedIn | Twitter | Blog


Ixesha lokuposa: Dec-24-2021